Back to Browse Journals » International Journal of General Medicine » Volume 2

Prevalence of hypersexual behavior in Parkinson’s disease patients: Not restricted to males and dopamine agonist use

Authors Christine A Cooper, Armon Jadidian, Michelle Paggi, Janet Romrell, Michael S Okun, et al

Published 20 March 2009 Volume 2009:2 Pages 57—61


Review by Single-blind

Peer reviewer comments 5

Christine A Cooper, Armon Jadidian, Michelle Paggi, Janet Romrell, Michael S Okun, et al

Department of Neurology, University of Florida, Gainesville, FL, USA

Abstract: This study investigates the prevalence and demographic characteristics of hypersexuality in Parkinson’s disease (PD). Impulse control disorders in PD patients have been associated with dopamine agonist therapy. Moreover, hypersexuality and pathological gambling have been associated with males, while females may be inherently thought to be more likely to participate in compulsive shopping and binge-eating behaviors. In this study, a screening mail-in survey was sent to all PD patients at a single Movement Disorders Center. One  hundred forty one of 400 (35.3%) research packets were returned completed. Fifteen of 141 patients met initial screening criteria for hypersexual behavior. After detailed interview, only 6/141 (4.3%) of PD patients met criteria for pathologic hypersexual behavior. These behaviors included: compulsive masturbation, prostitution, and paraphilias. Patients with a younger age of PD onset were more likely to exhibit hypersexual behavior. Unlike previous report, no significant association was found between hypersexuality and gender or dopamine agonist use. Rather, this study suggests that physicians should be vigilant for hypersexual behavior in all PD patients, regardless of gender and PD medication regimen. Ultimately, given the innate sensitivity of the topic and survey limitations, it is very likely that hypersexual behavior in our cohort, as it is in the general PD population, has been under-reported.

Keywords: Parkinson’s disease, hypersexuality, impulsive behavior, dopamine agonists

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Issues in assessing products for the treatment of hemophilia – the intersection between efficacy, economics, and ethics

Farrugia A, Noone D, Schlenkrich U, Schlenkrich S, O’Mahony B, Cassar J

Journal of Blood Medicine 2015, 6:185-195

Published Date: 15 June 2015

The neutrophil to lymphocyte ratio is associated with severity of rheumatic mitral valve stenosis

Baysal E, Burak C, Cay S, Aksu T, AltΔ±ntaş B, Yaylak B, Sevük U, Bilge Ö

Journal of Blood Medicine 2015, 6:151-156

Published Date: 13 May 2015

Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience

Rodriguez Garzotto A, Heine O, Turner M, Rebollo Laserna F, Lorenz A

Journal of Blood Medicine 2014, 5:43-48

Published Date: 28 April 2014

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Tivozanib in the treatment of renal cell carcinoma

Hepgur M, Sadeghi S, Dorff TB, Quinn DI

Biologics: Targets and Therapy 2013, 7:139-148

Published Date: 11 June 2013

Optimal management of carpal tunnel syndrome

Shimpei Ono, Philip J Clapham, Kevin C Chung

International Journal of General Medicine 2010, 3:255-261

Published Date: 26 August 2010

Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders

Pär I Johansson, Sisse R Ostrowski

Drug Design, Development and Therapy 2010, 4:107-116

Published Date: 29 June 2010

Synchronous bilateral breast cancer in a patient with Klinefelter’s syndrome

H M R Hoque, A Kothari, H Hamed, et al

International Journal of General Medicine 2010, 3:19-21

Published Date: 17 December 2009